Clinical Trial Update: Actinic Keratoses Treatment With Metvix® in Combination With Light [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating Metvix (methyl aminolevulinate) with light-based photodynamic therapy for actinic keratosis has completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Actinic Keratosis

Drugs mentioned

• Metvix (methyl aminolevulinate)

Snippet

Sponsor: University Hospital, Limoges | Conditions: Actinic Keratoses | Phase 3 | Status: COMPLETED | Results posted: 2019-04-08